- Home
- ZCMD vs RVPH Comparison
ZCMD vs RVPH Comparison
Compare ZCMD & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- RVPH
- Stock Information
- Founded
- ZCMD 2012
- RVPH 2006
- Country
- ZCMD China
- RVPH United States
- Employees
- ZCMD N/A
- RVPH N/A
- Industry
- ZCMD Other Consumer Services
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- RVPH Health Care
- Exchange
- ZCMD Nasdaq
- RVPH Nasdaq
- Market Cap
- ZCMD 29.0M
- RVPH 32.8M
- IPO Year
- ZCMD 2020
- RVPH N/A
- Fundamental
- Price
- ZCMD $1.16
- RVPH $0.40
- Analyst Decision
- ZCMD
- RVPH Strong Buy
- Analyst Count
- ZCMD 0
- RVPH 5
- Target Price
- ZCMD N/A
- RVPH $9.00
- AVG Volume (30 Days)
- ZCMD 597.6K
- RVPH 3.4M
- Earning Date
- ZCMD 01-01-0001
- RVPH 08-13-2025
- Dividend Yield
- ZCMD N/A
- RVPH N/A
- EPS Growth
- ZCMD N/A
- RVPH N/A
- EPS
- ZCMD N/A
- RVPH N/A
- Revenue
- ZCMD $15,864,773.00
- RVPH N/A
- Revenue This Year
- ZCMD N/A
- RVPH N/A
- Revenue Next Year
- ZCMD N/A
- RVPH N/A
- P/E Ratio
- ZCMD N/A
- RVPH N/A
- Revenue Growth
- ZCMD N/A
- RVPH N/A
- 52 Week Low
- ZCMD $0.95
- RVPH $0.30
- 52 Week High
- ZCMD $2.97
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- ZCMD 46.90
- RVPH 33.44
- Support Level
- ZCMD $1.12
- RVPH $0.35
- Resistance Level
- ZCMD $1.24
- RVPH $0.83
- Average True Range (ATR)
- ZCMD 0.13
- RVPH 0.06
- MACD
- ZCMD -0.01
- RVPH -0.01
- Stochastic Oscillator
- ZCMD 16.03
- RVPH 17.36
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.